首页> Nature medicine> Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

导出 OA

翻译打印收藏纠错

第一作者： Martin,Wermke

第一单位： Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.;National Center for Tumor Diseases, Dresden, Germany.

作者： Martin,Wermke ^[1] ; Dejka M,Araujo ^[2] ; Manik,Chatterjee ^[3] ; Apostolia M,Tsimberidou ^[4] ; Tobias A W,Holderried ^[5] ; Amir A,Jazaeri ^[6] ; Ran,Reshef ^[7] ; Carsten,Bokemeyer ^[8] ; Winfried,Alsdorf ^[9] ; Katrin,Wetzko ^[10] ; Peter,Brossart ^[5] ; Katrin,Aslan ^[11] ; Linus,Backert ^[11] ; Sebastian,Bunk ^[11] ; Jens,Fritsche ^[11] ; Swapna,Gulde ^[11] ; Silvana,Hengler ^[11] ; Norbert,Hilf ^[11] ; Mohammad B,Hossain ^[12] ; Jens,Hukelmann ^[11] ; Mamta,Kalra ^[12] ; Delfi,Krishna ^[12] ; M Alper,Kursunel ^[11] ; Dominik,Maurer ^[11] ; Andrea,Mayer-Mokler ^[11] ; Regina,Mendrzyk ^[11] ; Ali,Mohamed ^[12] ; Karine,Pozo ^[12] ; Arun,Satelli ^[12] ; Marilena,Letizia ^[11] ; Heiko,Schuster ^[11] ; Oliver,Schoor ^[11] ; Claudia,Wagner ^[11] ; Hans-Georg,Rammensee ^[13] ; Carsten,Reinhardt ^[11] ; Harpreet,Singh-Jasuja ^[11] ; Steffen,Walter ^[12] ; Toni,Weinschenk ^[11] ; Jason J,Luke ^[14] ; Cedrik M,Britten ^[15]

作者单位： Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany.;National Center for Tumor Diseases, Dresden, Germany. ^[1] Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[2] Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany. ^[3] Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[4] Department of Hematology, Oncology, Immunooncology, Stem Cell Transplantation, and Rheumatology, University Hospital Bonn, Bonn, Germany. ^[5] Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[6] Columbia University Medical Center, New York, NY, USA. ^[7] Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[8] Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[9] Department of Medicine I, University Hospital Carl Gustav Carus TU Dresden, Dresden, Germany. ^[10] Immatics Biotechnologies GmbH, Tübingen, Germany. ^[11] Immatics US, Inc., Houston, TX, USA. ^[12] Institute of Immunology, Eberhard Karls University Tübingen, Tübingen, Germany. ^[13] Cancer Immunotherapeutics Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA. ^[14] Immatics Biotechnologies GmbH, Tübingen, Germany. cedrik.britten@immatics.com. ^[15]